In 2012, the IDMIT Department received funding from the French Investments Program (PIA) for the creation of the National Infrastructure for Biology and Health, IDMIT, dedicated to the “Modeling of Infectious Diseases and Innovative Therapies.” This National Infrastructure draws on the expertise and knowledge of its internationally recognized founding institutions: CEA, Institut Pasteur, Université Paris-Saclay, and INSERM. All partners are global leaders in the field of host–pathogen interactions, contributing complementary expertise that has resulted in a preclinical entity unique in Europe for the study of human infectious diseases.
Highly innovative technologies, such as in vivo optical and nuclear imaging (via the L3i laboratory) combined with cell-scale technologies, are made available to the entire scientific community.